• NADH/NAD⁺ Redox Imbalance in Diabetic Kidney Disease: Mechan

  2026-05-06

  Yan (2021) synthesizes evidence that NADH/NAD⁺ redox imbalance is a central molecular driver of diabetic kidney disease (DKD), linking metabolic reprogramming and mitochondrial dysfunction to renal pathology. This review clarifies the pathways leading to NADH overproduction in diabetes and highlights the need for targeted strategies to restore redox homeostasis in DKD models.

• N1-Methylpseudouridine: Structure-Guided mRNA Engineering fo

  2026-05-06

  Discover how N1-Methylpseudouridine, a pioneering modified nucleoside, drives mRNA translation enhancement and reduced immunogenicity through advanced structural optimization strategies. Gain unique insights into its mechanistic role and practical assay implications, distinct from standard workflow guides.

• Curcumin–Piperlongumine Hybrid Targets EGFR-TKI-Resistant NS

  2026-05-05

  This study introduces a curcumin–piperlongumine hybrid molecule (CP) as a novel agent able to overcome EGFR-TKI resistance in non-small cell lung cancer. By integrating network pharmacology, molecular docking, and experimental validation, the research demonstrates CP’s unique capacity to induce apoptosis and inhibit proliferation in resistant cancer cells, highlighting its therapeutic promise.

• Pseudo-UTP: Optimizing mRNA Synthesis with Pseudo-Modified U

  2026-05-05

  Pseudo-UTP enables high-stability, low-immunogenicity RNA synthesis—critical for advanced mRNA vaccine and gene therapy workflows. This article translates the latest research and practical protocols into actionable guidance for maximizing your experimental success with APExBIO's Pseudo-UTP.

• Temozolomide: Small-Molecule Alkylating Agent for Glioma Res

  2026-05-04

  Temozolomide stands out as a precision small-molecule alkylating agent for dissecting DNA repair mechanisms and chemotherapy resistance, especially in ATRX-deficient glioma models. This guide translates recent translational breakthroughs and workflow best practices into actionable protocols, troubleshooting, and advanced assay strategies.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-05-04

  This study reveals that murine norovirus (MNoV) co-opts the host protein NINJ1 to selectively secrete its intracellular viral protein NS1, advancing the understanding of unconventional protein secretion and programmed cell death. The findings uncover a precise viral strategy for immune modulation and highlight new opportunities for dissecting membrane rupture mechanisms relevant to both virology and cancer research.

• N1-Methylpseudouridine: A Benchmark Modified Nucleoside for

  2026-05-03

  N1-Methylpseudouridine is a leading modified nucleoside that enhances mRNA translation efficiency while reducing immunogenicity. This article details its mechanism of action, validated benchmarks, and key workflow parameters for scientific use.

• E. coli Uracil-DNA Glycosylase (UDG): Practical Use Guide

  2026-05-02

  E. coli Uracil-DNA Glycosylase (UDG) provides a reliable solution for eliminating uracil-containing DNA contamination in PCR and DNA repair research workflows. This enzyme is not suitable for RNA substrates or oligonucleotides shorter than six bases, and should be reserved for scientific research applications only.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Optimizing

  2026-05-01

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 empowers researchers to rapidly produce ARCA-capped, polyadenylated, and immune-evasive mRNA for advanced therapeutic, translational, and immunological studies. Its streamlined workflow, robust yield, and immune-response mitigating modifications position it as a standout tool for RNA vaccine development and in vitro translation of modified mRNA.

• Applied Use of EZ Cap™ Human PTEN mRNA (ψUTP) in Cancer Rese

  2026-05-01

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers next-generation cancer research by delivering stable, immune-evasive mRNA for robust PTEN expression and PI3K/Akt pathway inhibition. This article breaks down experimental workflows, troubleshooting strategies, and the stepwise integration of this advanced mRNA tool, with actionable insights anchored in the latest nanoparticle-mediated delivery breakthroughs.

• Mitomycin C: Antitumor Antibiotic Workflows in Cancer Resear

  2026-04-30

  Mitomycin C is a gold-standard antitumor antibiotic that empowers apoptosis signaling research and advanced cancer models with robust, reproducible outcomes. Discover optimized protocols, data-backed troubleshooting, and decisive workflow enhancements for translational oncology, all supported by the reliability of APExBIO.

• EZ Cap™ Human PTEN mRNA (ψUTP): Next-Gen Stability for Funct

  2026-04-30

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP), a pioneering in vitro transcribed mRNA, uniquely advances cancer research through robust stability enhancement and immune modulation. This article delivers original insights into practical assay design and translational impact.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-04-29

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible, EDTA-free molecular weight standards for SDS-PAGE and Western blotting, resolving 10–250 kDa with distinct triple-color bands. It is designed for applications needing accurate size verification and transfer efficiency assessment, especially where compatibility with Phosbind SDS-PAGE or fluorescent imaging is required. This marker is not suitable for applications that require EDTA or extended storage at room temperature.

• RNA Pol II Inhibition Triggers Apoptosis via Non-Transcripti

  2026-04-29

  Harper et al. (2025) uncover that cell death upon RNA Pol II inhibition is driven by loss of the hypophosphorylated Pol IIA subunit, not by passive mRNA decay. This finding reveals an active, mitochondria-linked apoptotic pathway—distinct from canonical transcriptional responses—broadening the mechanistic understanding of cell death relevant to both basic and translational research.

• AO/PI Double Staining Kit: Technical Guidance for Cell Viabi

  2026-04-28

  The AO/PI Double Staining Kit provides a rapid, dual-fluorescent assay for distinguishing viable, apoptotic, and necrotic cells in a single workflow. Its use is recommended for cell biology researchers seeking reliable cell viability, apoptosis, and necrosis detection. The kit is not suitable for applications beyond fluorescence-based cell viability analysis or for samples incompatible with AO/PI fluorescent readouts.

766 records 19/52 page Previous Next First page 上5页 1617181920 下5页 Last page